Lipocortin-derived peptides
- 1 March 1994
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (6) , 931-938
- https://doi.org/10.1016/0006-2952(94)90402-2
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Crystal and molecular structure of human annexin V after refinement: Implications for structure, membrane binding and ion channel formation of the annexin family of proteinsJournal of Molecular Biology, 1992
- Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: Possible mechanism of actionLife Sciences, 1991
- Mutational analysis of the putative PLA2-inhibiting sequence of annexin 1FEBS Letters, 1991
- Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U‐937 cellsFEBS Letters, 1991
- Structure of soluble and membrane-bound human annexin VJournal of Molecular Biology, 1991
- ‘Antiflammins’: Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2 ‐inhibitory and anti‐inflammatory activityFEBS Letters, 1990
- Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.The Journal of Experimental Medicine, 1990
- Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretionBiochemical and Biophysical Research Communications, 1989
- Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activityFEBS Letters, 1989
- Protein tyrosine kinase substrates: Rosetta stones or simply structural elements?Trends in Pharmacological Sciences, 1988